Cargando…
Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma
BACKGROUND: Cuproptosis is a novel form of copper-induced cell death that targets lipoylated tricarboxylic acid (TCA) cycle proteins. However, its prognostic role in lung adenocarcinoma (LUAD) remains unclear. This study aimed to establish a cuproptosis-related prognostic signature for patients with...
Autores principales: | Chen, Yuqiao, Tang, Lu, Huang, Wentao, Zhang, Youyu, Abisola, Fakolade Hannah, Li, Linfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637654/ https://www.ncbi.nlm.nih.gov/pubmed/36353226 http://dx.doi.org/10.3389/fendo.2022.963220 |
Ejemplares similares
-
Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
por: Chen, Yuqiao, et al.
Publicado: (2023) -
Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023) -
Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022) -
Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
por: Lv, Yanju, et al.
Publicado: (2022) -
An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)